Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 1.00 |
| ▸ | FAAH | O00519 | 5/20 | 0.64 |
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | CASP2 | P42575 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8780431 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL94326 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL19281112 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL9565176 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL15994307 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL7924413 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL8660980 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL3318222 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL74418 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL23353 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1492762-B1 | PHOTOSTABLE CATIONIC ORGANIC SUNSCREEN COMPOUNDS WITH ANTIOXIDANT PROPERTIES AND COMPISITIONS OBTAINED THEREFROM | MERCK PATENT GMBH (DE) | 2007-11-14 | — | — | EP | disclosed |
| EP-1492762-A1 | PHOTOSTABLE CATIONIC ORGANIC SUNSCREEN COMPOUNDS WITH ANTIOXIDANT PROPERTIES AND COMPISITIONS OBTAINED THEREFROM | MERCK PATENT GmbH (DE) | 2005-01-05 | — | — | EP | disclosed |
| US-6699463-B2 | Photostable cationic organic sunscreen compounds with antioxidant properties and compositions obtained therefrom | EM INDUSTRIES | 2004-03-02 | — | — | US | disclosed |
| US-20030198607-A1 | Photostable cationic organic sunscreen compounds with antioxidant properties and compositions obtained therefrom | EM INDUSTRIES | 2003-10-23 | — | — | US | disclosed |
| WO-2003084920-A1 | PHOTOSTABLE CATIONIC ORGANIC SUNSCREEN COMPOUNDS WITH ANTIOXIDANT PROPERTIES AND COMPISITIONS OBTAINED THEREFROM | MERCK PATENT GMBH (DE) | 2003-10-16 | — | — | WO | disclosed |
| US-4220581-A | OF AMIDO AMINES, SOFTENERS, FIXATIVES, COSMETICS | NL INDUSTRIES, INC. (US) | 1980-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198607-A1 | Photostable cationic organic sunscreen compounds with antioxidant properties and compositions obtained therefrom | DOHH, CYC1, TYR | DNM1 4774/4885FAAH 225/4885NAAA 4572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.